Skip Main Navigation
Page Content

Horizon Discovery

Horizon Discovery combines deep scientific experience in translational research with a precision gene-editing platform incorporating rAAV, CRISPR and ZFN technologies.  Horizon acquired Dharmacon to create one company focused on the application of gene modification technologies for life science research positioning Horizon as a world leader in building, engineering, and modulating cells. Horizon’s comprehensive offering supplies genetically-defined cell lines, in vivo models, custom cell line generation, molecular reference standards, gene editing and gene expression tools to study gene function and contract research services to over 1,000 academic, clinical and biopharmaceutical organizations.

Save This Event

Event Saved